CBD Co. Says Accuser Must Turn Over Evidence In IP Case
A company accusing Medterra CBD of misappropriating a formula for a cannabinoid-infused lotion has yet to produce the emails where the alleged trade secrets were divulged, Medterra told a Florida federal...To view the full article, register now.
Already a subscriber? Click here to view full article